AKT1 and hepatocellular carcinoma: In other tumor entities, tumor cell‐ or stromal cell‐derived IL‐17 induces AKT signaling which is involved in cisplatin resistance of colorectal cancer [40] or EMT, invasion, and metastasis in hepatocellular carcinoma [41].